The Valley Desk

NCT00324220 · Interventional trial

A Phase I/II Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia

Overall registry status Completed

Phase 1 · Phase 2

Conditions Acute Myelogenous Leukemia, Myelodysplastic Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov